Lukasz Bolkun
Bialystok, PD, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Efficacy and tolerability of venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukemia - real-world analysis of Polish adult leukemia study group.
Journal: Leukemia & lymphoma
Published: August 10, 2026
Branching architecture of tryptophan metabolism determines therapeutic vulnerability in acute myeloid leukemia.
Journal: Cell death & disease
Published: February 23, 2026
Comprehensive geriatric assessment (CGA) scale does not effectively identify elderly AML patients suitable for intensive induction chemotherapy - a multicenter study from Polish Adult Leukemia Group.
Journal: Annals of hematology
Published: September 20, 2025
Indicators of an increased risk of therapy-related myeloid neoplasms in lymphoma patients: how can we best evaluate severe impairment of bone marrow function?
Journal: Expert review of hematology
Published: August 08, 2025
Multicenter retrospective analysis by the Polish Adult Leukemia Group on tuberculosis occurrence and outcomes after hematopoietic cell transplantation.
Journal: Scientific reports
Published: April 17, 2025
T-cell acute lymphoblastic leukemia with involvement of extramedullary sites, including the pericardium.
Journal: Kardiologia polska
Published: September 12, 2024
Investigation into biased signaling, glycosylation, and drug vulnerability of acute myeloid leukemia.
Journal: Pharmacology & therapeutics
Published: September 03, 2024
A hybrid protocol CLAG-M, a possible player for the first-line therapy of patients with mixed phenotype acute leukemia. A Polish Adult Leukemia Group experience.
Journal: Frontiers in oncology
Published: March 05, 2024
Effects of Combinatory In Vitro Treatment with Immune Checkpoint Inhibitors and Cytarabine on the Anti-Cancer Immune Microenvironment in De Novo AML Patients.
Journal: Cancers
Published: December 03, 2023
Richter transformation - retrospective treatment outcomes analysis in Polish Adult Leukemia Study Group.
Journal: Leukemia & lymphoma
Published: November 03, 2023
Therapeutic adherence and assessment of satisfaction patients with multiple myeloma treated with immunomodulatory drugs in a "real-world" study: Experiences of the Polish Myeloma Group.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: September 20, 2023
Prognostic factors and clinical characteristics of patients with newly diagnosed non-secretory multiple myeloma in the era of new drugs in "real-world" study: Experiences of the Polish Myeloma Group.
Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Published: August 27, 2023
Last Updated: 09/26/2026